SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

PSTI RSS Feed
Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, patentminer2013, n3m3sis
Search This Board: 
Last Post: 5/23/2017 10:18:21 PM - Followers: 133 - Board type: Free - Posts Today: 43

 

Pluristem Therapeutics Inc. (Nasdaq: PSTI) 

 

 

http://www.pluristem.com/

 

 


 

Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com

 

CIK:  0001158780

 

Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 

 

Management: 

http://www.pluristem.com/index.php/about2/management.html
 

Clinical Program: 

http://www.pluristem.com/index.php/clinic-program.html


Recent News and Press:

http://www.pluristem.com/index.php/press-room.html

http://finance.yahoo.com/q/h?s=PSTI+Headlines

http://seekingalpha.com/symbol/PSTI

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001158780&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


 

 

 

Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501

 

Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
karinek@pluristem.com


 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI
Current Price
Volume:
Bid Ask Day's Range
PSTI News: Pluristem Provides Shareholder Update on Corporate and Clinical Developments 05/22/2017 07:30:00 AM
PSTI News: Securities Registration: Employee Benefit Plan (s-8) 05/08/2017 04:28:19 PM
PSTI News: Quarterly Report (10-q) 05/08/2017 04:09:39 PM
PSTI News: Current Report Filing (8-k) 05/03/2017 04:10:04 PM
PSTI News: Pluristem Announces Promising Results from Non-Human Primate Pilot Study of PLX-R18 in Acute Radiation Syndrome 05/03/2017 07:00:00 AM
PostSubject
#4193  Sticky Note Here is the Seeking Alpha interview which is patentminer2013 03/04/17 05:43:28 PM
#5210   evan more interesting now, sounds like it could thesaud 05/23/17 10:18:21 PM
#5209   Tomorrow ! FDApproved 05/23/17 09:20:00 PM
#5208   Looky What I Just Found ! FDApproved 05/23/17 08:35:17 PM
#5207   Well put. Thank you. Investing has risks and TC43 05/23/17 07:41:38 PM
#5206   Interesting ! FDApproved 05/23/17 07:41:12 PM
#5205   Sosei Shares Climb Most in Three Years on bluehorsesho 05/23/17 06:04:17 PM
#5204   Please quit with the shouting already. n3m3sis 05/23/17 05:52:32 PM
#5203   I STILL SAY SOSEI DEAL STINKS AND I HAVE bluehorsesho 05/23/17 05:24:35 PM
#5202   To: Thesaud... Yes, I Found That Rather Interesting. FDApproved 05/23/17 04:34:33 PM
#5201   that's right allo its very interesting they are thesaud 05/23/17 04:22:19 PM
#5200   ZAMI HAS PUBLICALLY STATED THAT THE 'COMPANY' IS FDApproved 05/23/17 04:21:32 PM
#5199   You are exactly right Allo... Management has been Melon4head 05/23/17 04:01:01 PM
#5198   THANKS FOR VERIFYING MY SUSPICIONS ! FDApproved 05/23/17 03:54:46 PM
#5197   SO, IT MEANS NOTHING, HIM AND YAKY have... bluehorsesho 05/23/17 03:52:02 PM
#5196   YELLING DOESN'T HELP, why does the question... bluehorsesho 05/23/17 03:48:38 PM
#5195   ZAMI IS ON A PANEL TOMORROW WITH..... FDApproved 05/23/17 03:43:08 PM
#5194   The Possibility Of A Better Deal is Not FDApproved 05/23/17 03:39:54 PM
#5193   Sosei signs alliance for R & D of bluehorsesho 05/23/17 03:39:07 PM
#5192   Sosei Group unit signs investment agreement with MiNA bluehorsesho 05/23/17 03:35:41 PM
#5191   your missing the point, option to buy and bluehorsesho 05/23/17 03:32:44 PM
#5190   Because Pluristem Is Not For Sale ! FDApproved 05/23/17 03:22:37 PM
#5189   Any Ideas why Sosei Bought another company last week.... bluehorsesho 05/23/17 03:14:19 PM
#5188   Baylor University Medical Center Began Recruiting For PLX-R18 FDApproved 05/23/17 03:01:51 PM
#5187   Sosei just paid 45m for Mina Therapeutics, why bluehorsesho 05/23/17 02:44:36 PM
#5186   Between 3 and 5 million people in the bluehorsesho 05/23/17 02:00:45 PM
#5185   Sosei Group agreed on Tuesday to pay £35m bluehorsesho 05/23/17 01:54:32 PM
#5184   Radiation threats Pocket-size biological solution to radioactive threats bluehorsesho 05/23/17 12:58:42 PM
#5183   TAILOR MADE FOR COMPANIES LIKE PLURISTEM ! INCREDIBLE FDApproved 05/23/17 11:57:22 AM
#5182   SWEET ! Long-Time Share-Holders Have Filed a 13G..... FDApproved 05/23/17 11:38:59 AM
#5181   Case in point. Spideyboy 05/23/17 10:51:18 AM
#5179   Most welcome, Spideyboy 05/23/17 10:20:29 AM
#5178   keep up the great post, I do not bluehorsesho 05/23/17 10:09:27 AM
#5177   Controller Working Hard To Keep It Near $ FDApproved 05/23/17 10:04:54 AM
#5176   Well, let's not get ahead of ourselves. Spideyboy 05/23/17 10:04:37 AM
#5175   18 months I will be a millionaire, Data bluehorsesho 05/23/17 09:47:14 AM
#5174   180 Billion ! WOW ! FDApproved 05/23/17 08:54:58 AM
#5173   9 MILLION X $20,000.00 THAT'S AN 18 BILLION FDApproved 05/23/17 07:33:37 AM
#5172   Great find regarding potential Japanese market size. Spideyboy 05/23/17 07:23:39 AM
#5171   According to THE SAGE GROUP, 1 Million or FDApproved 05/23/17 06:09:23 AM
#5169   CHINA IS HUNGRY FOR PLACENTA POWER ! FDApproved 05/23/17 03:56:12 AM
#5168   Pretty clever Blue!!! Melon4head 05/23/17 01:05:32 AM
#5167   gunsnkars Monday, 05/22/17 09:55:45 AM Auto1 05/22/17 11:37:38 PM
#5166   https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125031s180lbl.pdf Auto1 05/22/17 11:33:57 PM
#5165   Definitely (SP), not the smartest! Auto1 05/22/17 11:31:01 PM
#5164   Dear gunsnkars, Auto1 05/22/17 11:26:48 PM
#5163   Carpenters? I would say we are in the bluehorsesho 05/22/17 10:33:02 PM
#5162   Thank the TWO Great CEO's, Breath of Fresh Air..... bluehorsesho 05/22/17 10:18:25 PM
#5161   Shelf Life Comparison is so important to cost Melon4head 05/22/17 10:13:51 PM
#5160   Just saw the News, Nice Call FDA about having.... bluehorsesho 05/22/17 06:14:09 PM
#5159   I Told You ! The Stock Has Been FDApproved 05/22/17 04:05:18 PM
PostSubject